Stock News

The Chemours Company (CC) Analysts See $1.23 EPS; Cbak Energy Technology (CBAK) SI Decreased By 5.89%

The Chemours Company (NYSE:CC) Logo

Cbak Energy Technology Inc (NASDAQ:CBAK) had a decrease of 5.89% in short interest. CBAK’s SI was 204,700 shares in April as released by FINRA. Its down 5.89% from 217,500 shares previously. With 24,400 avg volume, 8 days are for Cbak Energy Technology Inc (NASDAQ:CBAK)’s short sellers to cover CBAK’s short positions. The SI to Cbak Energy Technology Inc’s float is 0.92%. It closed at $1.35 lastly. It is down 12.00% since April 17, 2017 and is uptrending. It has outperformed by 0.45% the S&P500.

Analysts expect The Chemours Company (NYSE:CC) to report $1.23 EPS on May, 3 after the close.They anticipate $0.48 EPS change or 64.00% from last quarter’s $0.75 EPS. CC’s profit would be $223.23M giving it 10.61 P/E if the $1.23 EPS is correct. After having $1.19 EPS previously, The Chemours Company’s analysts see 3.36% EPS growth. The stock increased 1.76% or $0.9 during the last trading session, reaching $52.18. About 541,503 shares traded. The Chemours Company (NYSE:CC) has risen 35.56% since April 17, 2017 and is uptrending. It has outperformed by 24.01% the S&P500.

CBAK Energy Technology, Inc., through its subsidiaries, develops, makes, and sells energy high power lithium batteries in the PeopleÂ’s Republic of China, Europe, South Korea, and Israel. The company has market cap of $35.40 million. The Company’s products are used in various applications, including electric vehicles, such as electric cars, electric buses, and hybrid electric cars and buses; light electric vehicles that include electric bicycles, electric motors, and sight-seeing cars; and electric tools, energy storage, uninterruptible power supply, and other high power applications, as well as cordless power tools. It currently has negative earnings. The firm was formerly known as China BAK Battery, Inc. and changed its name to CBAK Energy Technology, Inc. in January 2017.

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company has market cap of $9.47 billion. It operates through three divisions: Titanium Technologies, Fluoroproducts, and Chemical Solutions. It has a 13.35 P/E ratio. The Titanium Technologies segment makes and sells titanium dioxide under the Ti-Pure brand name to deliver whiteness, brightness, opacity, and protection in various applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, PVC window profiles, laminate papers, and coated papers and paperboards used for packaging.

Investors sentiment decreased to 0 in Q4 2017. Its down 1.00, from 1 in 2017Q3. It dropped, as 0 investors sold The Chemours Company shares while 1 reduced holdings. 0 funds opened positions while 0 raised stakes. 7,523 shares or 1.43% less from 7,632 shares in 2017Q3 were reported. Gemmer Asset Management Lc holds 0.02% or 1,082 shares. Balasa Dinverno And Foltz Limited Liability Corporation has invested 0.05% in The Chemours Company (NYSE:CC).

Among 10 analysts covering Chemours (NYSE:CC), 7 have Buy rating, 0 Sell and 3 Hold. Therefore 70% are positive. Chemours had 38 analyst reports since July 27, 2015 according to SRatingsIntel. The stock of The Chemours Company (NYSE:CC) earned “Neutral” rating by Goldman Sachs on Monday, December 12. The rating was upgraded by JP Morgan to “Neutral” on Friday, August 7. Jefferies maintained The Chemours Company (NYSE:CC) on Thursday, September 1 with “Hold” rating. Jefferies maintained the stock with “Buy” rating in Wednesday, September 6 report. The company was upgraded on Wednesday, August 10 by Argus Research. The company was initiated on Friday, September 18 by Argus Research. Susquehanna maintained The Chemours Company (NYSE:CC) rating on Friday, February 16. Susquehanna has “Buy” rating and $61.0 target. The stock has “Buy” rating by Citigroup on Wednesday, July 5. The firm has “Underweight” rating given on Friday, August 7 by JP Morgan. Susquehanna initiated The Chemours Company (NYSE:CC) rating on Monday, July 27. Susquehanna has “Neutral” rating and $13 target.

The Chemours Company (NYSE:CC) Ratings Chart

Leave a Reply

Your email address will not be published. Required fields are marked *